Compare INKT & PODC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | INKT | PODC |
|---|---|---|
| Founded | 2017 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 45.2M | 59.2M |
| IPO Year | 2021 | 2022 |
| Metric | INKT | PODC |
|---|---|---|
| Price | $10.57 | $2.08 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $35.00 | N/A |
| AVG Volume (30 Days) | ★ 171.9K | 40.1K |
| Earning Date | 05-14-2026 | 02-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $21.33 |
| Revenue Next Year | N/A | $19.04 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $6.66 | $1.30 |
| 52 Week High | $76.00 | $3.35 |
| Indicator | INKT | PODC |
|---|---|---|
| Relative Strength Index (RSI) | 53.07 | 40.24 |
| Support Level | $8.48 | $1.89 |
| Resistance Level | $12.97 | $2.40 |
| Average True Range (ATR) | 0.97 | 0.17 |
| MACD | 0.19 | -0.02 |
| Stochastic Oscillator | 64.74 | 17.67 |
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. The company is advancing a pipeline of both native and next generation engineered iNKT programs, with a platform designed to facilitate scalable and reproducible manufacturing for off-the-shelf delivery.
PodcastOne Inc is a podcast platform and publisher that makes its content available to audiences via all podcasting distribution platforms, including its website, its PodcastOne app, Apple Podcasts, Spotify, Amazon Music, and more.